Cubist Pharmaceuticals Inc news

   Watch this stock
Showing stories 11 - 20 of about 92   

Articles published

CBST 68.20 +3.06 (4.70%)
price chart
RSI Alert: Cubist Pharmaceuticals (CBST) Now Oversold
In trading on Monday, shares of Cubist Pharmaceuticals Cubist Pharmaceuticals Inc. (NASD: CBST) entered into oversold territory, hitting an RSI reading of 29.2, after changing hands as low as $65.76 per share.
Related articles »  
Cubist Pharmaceuticals Inc.: Cubist to Announce First Quarter 2014 Financial ...
LEXINGTON, Mass.--(BUSINESS WIRE)-- Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) will issue its first quarter 2014 financial results at 4:00 p.m.
Active Movers - Organovo Holdings Inc (NYSEMKT:ONVO), Cubist ...  Techsonian (press release)
Related articles »  
Cubist Pharmaceuticals Given �Buy� Rating at Aegis (CBST)
Cubist Pharmaceuticals Inc logo Cubist Pharmaceuticals (NASDAQ:CBST)'s stock had its �buy� rating reiterated by analysts at Aegis in a research report issued to clients and investors on Tuesday, Analyst Ratings Network reports.
Cubist Appoints Robert J. Perez to Board of Directors
From 1987 to 1995, Mr. Perez held various sales and marketing positions at Zeneca Pharmaceuticals. Mr. Perez is a Director at AMAG Pharmaceuticals, Inc. and from 2006 - 2009 served as a Director at EPIX Pharmaceuticals, Inc. He is also a Trustee of the ...
Related articles »  
Cubist Pharma Submits NDA For Investigational Antibiotic Ceftolozane/tazobactam
Cubist Pharmaceuticals Inc. (CBST: Quote) announced Monday that it has submitted a New Drug Application or NDA to the U.S. Food and Drug Administration or FDA for approval of its investigational antibiotic ceftolozane/tazobactam for the treatment of ...
Cubist Announces Submission of New Drug Application for Investigational ...  PipelineReview.com (press release)
Related articles »  
Cubist Pharma Recalls One Lot Of Cubicin Due To Presence Of Particulate Matter
(RTTNews.com) - Cubist Pharmaceuticals, Inc. ( CBST ) said Friday that it is voluntarily recalling one lot of Cubicin to the user level due to the presence of particulate matter, reported through customer complaint and identified as glass particles ...
Volatile Movements-Cubist Pharmaceuticals Inc (CBST), Microvision, Inc. (MVIS ...
Cubist Pharmaceuticals Inc (NASDAQ:CBST) decreased -4.97% and closed at $70.35 on a traded volume of 1.13 million shares, in comparison to 753,707.00 shares of average trading volume.
News Recap - TherapeuticsMD Inc (NYSEMKT:TXMD), Alnylam ...
Cubist Pharmaceuticals Inc (NASDAQ:CBST) reported 1.50 million shares were exchanged during the last trade, while the average volume is about 794,229 shares.
Related articles »  
Why MannKind (MNKD) is Outpacing these Biotech Stocks, Questcor ...
Cubist Pharmaceuticals, Inc. (NASDAQ:CBST) shares moved up 2% after the company reported that it would issue its first quarter 2014 financial results at 4:00 p.m.
Related articles »  
Cubist Pharmaceuticals Price Target Raised to $73.00 at Cantor Fitzgerald (CBST)
Cubist Pharmaceuticals Inc logo Cubist Pharmaceuticals (NASDAQ:CBST) had its price target increased by Cantor Fitzgerald to $73.00 in a research report sent to investors on Thursday morning, StockRatingsNetwork.
Cantor Fitzgerald Increases Cubist Pharmaceuticals Price Target to $73.00 (CBST)  Zolmax
Related articles »